Menu
Not yet recruiting NCT07534683

Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological and Workplace Outcomes

No phase Interventional Workplace Wellbeing

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Meditation, Mindful Educational Material.
Who it may be relevant to
Registry conditions: Workplace Wellbeing. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological and Workplace Outcomes (BEGIN III)

Overview

Employees commonly experience stress and reduced well-being that can affect workplace functioning. This interventional study will evaluate whether combining mindfulness-related educational materials with a brief daily guided meditation practice delivered through a smartphone application improves psychological well-being and workplace outcomes compared with educational materials alone. Adult employees will be randomized to receive the meditation plus educational materials during the initial intervention period or after a waitlist period, with assessments completed at multiple time points over approximately 12 weeks. The primary outcome will evaluate change in work engagement using the Utrecht Work Engagement Scale (UWES-9).

Interventions

  • Behavioral Meditation
    Participants engage in a minimum of 7 minutes of daily guided meditation via the Miracle of Mind program, delivered through the 3C's app, during their assigned intervention period (Weeks 1-4 for the intervention group; Weeks 5-8 for the waitlist control group). The practice involves voice-guided seated meditation with simple breathing techniques and chants. App- and email-based reminders are provided during the active intervention period only.
  • Behavioral Mindful Educational Material
    Participants receive access to work-related mindfulness educational materials throughout the full 12-week study period via the 3C's app. Materials are derived from Sadhguru's teachings and address topics including stress management, communication, and work-life balance. Both groups receive these materials to ensure comparable engagement and provide a control condition for evaluating the specific effects of meditation.

Primary outcome measures

  • Work Engagement (UWES-9) [Time frame: Baseline T1 toT2 - Intervention Phase I (Weeks 1-4)]
Secondary outcome measures (1)
  • Stress (PSS) [Time frame: Baseline T1 to T4 ((Week 1- Week 12)]

Eligibility criteria

Inclusion criteria

  • Individuals aged 18 years or older.
  • Current employee of the participating company who expresses interest in participating in the study.
  • Subjects will be required to be able to understand study instructions and materials and provide informed consent.
  • Willing and able to download and use a smartphone application compatible with iOS or Android platforms.

Exclusion criteria

  • Insufficient proficiency in English to comprehend study materials and instructions.
  • Presence of a diagnosed mental health condition that may interfere with the capacity to engage in or benefit from meditation practices, as determined by self-report or clinical history.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07534683 · 2026P000023

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗